Student Information and Liability Forms
Dear OVAS applicant,
Thank you for completing an OVAS Application for you or your child’s participation in our program. Once received, it is reviewed and filed. Your application and liability forms must be signed and updated annually. Upon completion of your application and liability paperwork you must contact us directly in order to schedule appointments for the season. The information you provide is confidential and used solely for educational and safety purposes.
Guidelines: The participant must be at least 4 years old and have a documented physical or cognitive special need.
Please know that participation in OVAS activities involves risk. Providing a high quality program in a risk-managed environment is a priority at OVAS, however, we cannot eliminate all risks of snow skiing or boarding. These activities can cause minor or serious injuries. As with any outdoor adventure, under rare circumstances, the activity can even result in death.
It is of utmost importance to us that you not engage in activities that are opposed by you, your family, or your doctor due to illness, physical or mental infirmity, or any other health/medical condition that you may have, whether diagnosed or undiagnosed.
In order to manage these risks, it is very important that all program participants follow all directions given by OVAS staff. Please ask questions whenever a procedure or activity is unclear to you. If a program participant currently is taking prescription medications, including medical marijuana or other alternative therapies, it is imperative that these medications be disclosed in the confidential medical form. Use of or being under the influence of alcohol or judgment affecting drugs while participating in adventure activities is unsafe and strictly prohibited.
We believe that it is in everyone’s interest that risks are disclosed, understood, and accepted prior to participation with OVAS. All Liability Forms will be available for you to sign at the first lesson.
If you have any questions or comments about this release or the level of risk at OVAS, please do not hesitate to contact us. We welcome your questions, suggestions and feedback.